Camden Property Trust (CPT) Reaches $85.54 After 5.00% Up Move; Agilent Technologies (A) SI Decreased By 33.97%

May 23, 2018 - By Louis Casey

Agilent Technologies, Inc. (NYSE:A) Logo

Agilent Technologies Inc (NYSE:A) had a decrease of 33.97% in short interest. A’s SI was 3.75 million shares in May as released by FINRA. Its down 33.97% from 5.68M shares previously. With 2.36 million avg volume, 2 days are for Agilent Technologies Inc (NYSE:A)’s short sellers to cover A’s short positions. The stock decreased 0.20% or $0.13 during the last trading session, reaching $64.71. About 772,728 shares traded. Agilent Technologies, Inc. (NYSE:A) has risen 25.85% since May 23, 2017 and is uptrending. It has outperformed by 14.30% the S&P500.

The stock of Camden Property Trust (NYSE:CPT) is a huge mover today! The stock increased 1.90% or $1.599 during the last trading session, reaching $85.539. About 104,810 shares traded. Camden Property Trust (NYSE:CPT) has risen 1.59% since May 23, 2017 and is uptrending. It has underperformed by 9.96% the S&P500.The move comes after 7 months positive chart setup for the $8.37 billion company. It was reported on May, 23 by We have $89.82 PT which if reached, will make NYSE:CPT worth $418.40M more.

Analysts await Camden Property Trust (NYSE:CPT) to report earnings on July, 26. They expect $1.17 EPS, up 1.74% or $0.02 from last year’s $1.15 per share. CPT’s profit will be $114.46 million for 18.28 P/E if the $1.17 EPS becomes a reality. After $1.15 actual EPS reported by Camden Property Trust for the previous quarter, Wall Street now forecasts 1.74% EPS growth.

Investors sentiment decreased to 1.37 in Q4 2017. Its down 0.03, from 1.4 in 2017Q3. It is negative, as 30 investors sold Camden Property Trust shares while 83 reduced holdings. 37 funds opened positions while 118 raised stakes. 87.77 million shares or 0.54% less from 88.25 million shares in 2017Q3 were reported. 67,717 are held by Nomura Asset Management Limited. Ohio-based Huntington Comml Bank has invested 0% in Camden Property Trust (NYSE:CPT). The South Carolina-based South State has invested 0.13% in Camden Property Trust (NYSE:CPT). Bahl Gaynor has 0.13% invested in Camden Property Trust (NYSE:CPT) for 136,637 shares. Bbva Compass Bancorp Incorporated invested in 0.02% or 2,601 shares. Westpac Banking Corp invested in 140,637 shares or 0.29% of the stock. Brown Brothers Harriman And Communications has invested 0% in Camden Property Trust (NYSE:CPT). Morgan Stanley reported 0.05% stake. State Treasurer State Of Michigan reported 33,300 shares stake. 4,596 are owned by Keybank National Association Oh. Manufacturers Life Insur The reported 0.02% in Camden Property Trust (NYSE:CPT). Fincl Bank Of America Corp De owns 521,797 shares or 0.01% of their US portfolio. Fisher Asset Mgmt Ltd Liability Com invested 0.01% of its portfolio in Camden Property Trust (NYSE:CPT). Panagora Asset Mgmt Inc has invested 0% in Camden Property Trust (NYSE:CPT). Alpine Woods Cap Invsts Limited reported 0.22% stake.

Camden Property Trust is an independent real estate investment trust. The company has market cap of $8.37 billion. The firm invests in the real estate markets of the United States. It has a 39.86 P/E ratio. It is engaged in the ownership, development, acquisition, management, and disposition of multifamily residential apartment communities.

Since December 8, 2017, it had 0 insider purchases, and 4 selling transactions for $10.39 million activity. Shares for $4.82M were sold by CAMPO RICHARD J on Friday, December 8. Sengelmann William W. sold $395,963 worth of stock or 4,478 shares. $5.14M worth of Camden Property Trust (NYSE:CPT) was sold by ODEN D KEITH. The insider WESTBROOK KELVIN R sold $37,579.

Among 22 analysts covering Camden Property (NYSE:CPT), 12 have Buy rating, 0 Sell and 10 Hold. Therefore 55% are positive. Camden Property has $105.0 highest and $77 lowest target. $88.85’s average target is 3.87% above currents $85.539 stock price. Camden Property had 77 analyst reports since July 21, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Monday, August 24 by Zacks. The rating was maintained by Sandler O’Neill on Monday, February 5 with “Buy”. The firm has “Hold” rating given on Monday, September 11 by Robert W. Baird. The firm has “Buy” rating given on Wednesday, January 24 by BMO Capital Markets. The company was maintained on Thursday, August 31 by Stifel Nicolaus. The firm has “Buy” rating by BMO Capital Markets given on Monday, July 3. The firm earned “Neutral” rating on Monday, March 19 by UBS. On Monday, August 14 the stock rating was downgraded by Evercore to “In-Line”. The stock of Camden Property Trust (NYSE:CPT) earned “Buy” rating by Evercore on Monday, August 24. The rating was maintained by Barclays Capital with “Equal-Weight” on Tuesday, July 18.

More recent Camden Property Trust (NYSE:CPT) news were published by: which released: “Recent Analysis Shows Camden Property Trust, Biglari, Argan, Chimerix, Workhorse Group, and Magellan Midstream …” on May 17, 2018. Also published the news titled: “Camden Property Trust’s (CPT) CEO Ric Campo on Q1 2018 Results – Earnings Call Transcript” on May 04, 2018.‘s news article titled: “Camden Property Trust Announces First Quarter 2018 Operating Results” with publication date: May 03, 2018 was also an interesting one.

More notable recent Agilent Technologies, Inc. (NYSE:A) news were published by: which released: “Agilent Signs Agreement to Acquire Assets from Young In Scientific Co. Ltd.” on May 23, 2018, also with their article: “Agilent Technologies (A) Reports Agreement to Acquire Assets from Young In Scientific Co. Ltd.” published on May 23, 2018, published: “Stocks To Watch: A Fed Head Talks Crypto” on May 12, 2018. More interesting news about Agilent Technologies, Inc. (NYSE:A) were released by: and their article: “Agilent Technologies, Inc. (NYSE:A) Declines 9.70%” published on May 16, 2018 as well as‘s news article titled: “The Week Ahead: Are You Still Worried About A Bear Market?” with publication date: May 19, 2018.

Investors sentiment decreased to 0.95 in 2017 Q4. Its down 0.45, from 1.4 in 2017Q3. It dropped, as 40 investors sold Agilent Technologies, Inc. shares while 198 reduced holdings. 62 funds opened positions while 164 raised stakes. 269.93 million shares or 0.89% more from 267.56 million shares in 2017Q3 were reported. Fincl Counselors reported 27,107 shares. Credit Suisse Ag invested in 0.03% or 487,526 shares. Aviva Public Ltd Com accumulated 179,466 shares or 0.07% of the stock. Glg Limited Liability Corp owns 60,812 shares. Private Advisor Ltd Llc has 0.01% invested in Agilent Technologies, Inc. (NYSE:A) for 4,351 shares. Moreover, Everence Cap Incorporated has 0.08% invested in Agilent Technologies, Inc. (NYSE:A). Koch Industrial Incorporated invested in 4,782 shares. Robecosam Ag has 485,515 shares. Fuller & Thaler Asset Mgmt invested in 1,500 shares or 0% of the stock. The Ohio-based Victory has invested 0.41% in Agilent Technologies, Inc. (NYSE:A). Verition Fund Mngmt Ltd Liability holds 0.15% or 23,661 shares. Bessemer Grp Inc Inc stated it has 0% of its portfolio in Agilent Technologies, Inc. (NYSE:A). Ww Asset holds 27,038 shares or 0.06% of its portfolio. Amica Retiree Medical Tru stated it has 1,759 shares. Eaton Vance Management reported 1.11 million shares or 0.18% of all its holdings.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company has market cap of $20.87 billion. The Company’s Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; laboratory software and informatics systems; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies. It has a 107.85 P/E ratio. The companyÂ’s Diagnostics and Genomics segment provides reagents, instruments, software, and consumables; arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment services; and equipment focused on production of synthesized oligonucleotides for use as active pharmaceutical ingredients.

Camden Property Trust (NYSE:CPT) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: